Pain in Inflammatory Joint Diseases

Plain-language summary

This study looks at pain in people with inflammatory joint diseases as they start or switch biological or targeted synthetic DMARD treatments. All patients who begin or change these treatments can take part. It is a study with no applicable phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Diakonhjemmet Hospital

Intervention

Biological or targeted synthetic DMARD

Start date

11/11/2025

Estimated completion

11/1/2027

Countries

Norway

Related genes

Locations

• Oslo, Norway

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* All patients who initiate or switch biological or targeted synthetic DMARDs

Exclusion Criteria:

* None